REVERPLEG 40 U.I./2 mL
Sponsors
Centre Hospitalier Universitaire Dijon Bourgogne, Assistance Publique Hopitaux De Paris, Centre Hospitalier Universitaire De Dijon
Conditions
Acute Kidney InjuryLiver transplantationnorepinephrine-refractory vasoplegic shockvasoplegic syndrome
Phase 3
Prospective randomized double-blind study evaluating the superiority of VAsopressin versus NOradrenaline in the management of the renal risk patient undergoing cardiac surgery with extracorporeal circulation
Active, not recruitingCTIS2022-500419-38-00
Start: 2022-12-28Target: 840Updated: 2023-08-23
Effect of low-dose arginine-vasopressin supplementation on post-transplant Acute Kidney Injury after liver transplantation - AVENIR Trial
RecruitingCTIS2023-506512-40-00
Start: 2025-04-16Target: 304Updated: 2025-12-19
Efficacy of early Argipressin (arginine vasopressin) in the management of intensive care patients with norepinephrine-refractory vasoplegic shock: a multicentric randomized, double-blind placebo-controlled superiority trial : Vaso²R
Not yet recruitingCTIS2024-516639-28-00
Target: 390Updated: 2026-01-14